Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| CTEV | CLARITEV CORP | $279.58M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CLFD | CLEARFIELD INC | $389.35M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LION | LIONSGATE STUDIOS CORP | $2.82B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $209.10M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.50B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RLMD | RELMADA THERAPEUTICS INC | $433.40M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $517.77M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $7.71B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SLDB | SOLID BIOSCIENCES INC | $569.52M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PCVX | VAXCYTE INC | $7.86B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CGEM | CULLINAN THERAPEUTICS INC | $816.50M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MITT | TPG MORTGAGE INVESTMENT TRUST INC | $236.11M | 8.60% | 94.40% | $0.2300 | $0.64 | 92% | 5 | ||
| DMRA | DAMORA THERAPEUTICS INC | $34.95M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ONC | BEONE MEDICINES LTD | $31.54B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GIL | GILDAN ACTIVEWEAR INC | $10.86B | 0.39% | 34.60% | $0.2260 | $0.23 | 7% | 1 | ||
| VKTX | VIKING THERAPEUTICS INC | $4.12B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.01B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $727.50M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TRVI | TREVI THERAPEUTICS INC | $1.41B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.29B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NTSK | NETSKOPE INC | $3.83B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| IKT | INHIBIKASE THERAPEUTICS INC | $150.35M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MPLT | MAPLIGHT THERAPEUTICS INC | $865.26M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| TLX | TELIX PHARMACEUTICALS LTD | $2.66B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| RACE | FERRARI NV | $58.83B | N/A | 32.50% | $2.4430 | N/A | N/A | 0 | ||
| GLOO | GLOO HOLDINGS INC | $478.99M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| TTAN | SERVICETITAN INC | $6.63B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FLR | FLUOR CORP | $6.31B | N/A | 0.00% | $0.1000 | N/A | N/A | 1 | ||
| IPHA | INNATE PHARMA SA | $130.41M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARVN | ARVINAS INC | $779.04M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PAR | PAR TECHNOLOGY CORP | $607.82M | N/A | 0.00% | $0.3100 | N/A | N/A | 0 | ||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $2.13B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CRVO | CERVOMED INC | $39.35M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RZLT | REZOLUTE INC | $248.34M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SYNA | SYNAPTICS INC | $2.86B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| OFIX | ORTHOFIX MEDICAL INC | $469.69M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KYTX | KYVERNA THERAPEUTICS INC | $391.98M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.